DFDA

Amoxicillin/Clavulanate

Treatment for Lower Respiratory Infections

Typical Dosage: 875 mg/125 mg twice daily

Effectiveness
88%
Safety Score
70%
Clinical Trials
1
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanideโ˜ ๏ธ
Meth๐Ÿ’€
Cigarettes๐Ÿšฌ
Chemoโ˜ข๏ธ
Alcohol๐Ÿบ
Morphine๐Ÿ’Š
Antibiotics๐Ÿ’‰
Tylenol๐Ÿ’Š
Exercise๐Ÿƒ
Water๐Ÿ’ง
70
DangerousModerateSafe
Treatment Details
Dosage Range
875 mg/125 mg twice daily
Time to Effect
1-2 days
Treatment Duration
7-10 days
Evidence Quality
HIGH
Number Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
8(Treat 8 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$45
Monitoring:$250
Side Effect Mgmt:$10
Total Annual:$305
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$25,000/QALY
QALYs Gained
0.09
Outcome-Based Costs
Cost per Responder
$338.89
Cost per Remission
$358.82
Comparison vs Amoxicillin
Cost Difference
+$30/year
More expensive
QALY Difference
+0.01 QALYs
Better outcomes
Dominance
No dominance
Prescription Access Economics
Physician Visit Cost
$150/year
Time Cost
$30/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$45/year
Potential OTC Price
$27.5/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
LOW
Amoxicillin/Clavulanate Outcomes

for Lower Respiratory Infections

Efficacy Outcomes
Overall Effectiveness
+88%
Response Rate
+90%
Remission Rate
+85%
Common Side Effects
Diarrhea
+12%
Nausea/vomiting
+6%
Rash
+2%
Hepatotoxicity
+0.05%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Amoxicillin/Clavulanate in Lower Respiratory Infections

Community-Acquired Pneumonia - Study on the Initial Treatment With Antibiotics of Lower Respiratory Tract Infections

NCT01660204COMPLETEDNA
View Study
2.28K participants
INTERVENTIONAL
Alkmaar, Netherlands +6 more
Started: Feb 1, 2011